 |
SYDNEY, Aug. 7, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has awarded Rare Pediatric Disease Designation (RPDD) to Kazia's paxalisib (formerly GDC-0084) for the treatment of...
With the National Electric Vehicle Strategy due for a comprehensive review during 2026, automotive expert and senior government advisor, Raffy Sgroi, warns that Australia is rushing electric vehic...
Daily Bulletin
China Gold Coin Group Co., Ltd. unveiled its 2026 Chinese Dragon Silver Bullion Coin at the World Money Fair held in Berlin, Germany, from January 29 to 31. Led by Mr Jinpu Jiao, Chairman of the Boa...
Daily Bulletin
Running a business is all about making the right decisions. When it comes to choosing an industrial air compressor, that decision becomes even more critical. Air compressors are long-term investment...
Daily Bulletin
